Majority of Patients with C Diff Willing to Use Rectally Administered Treatment
Survey results showed patients with a history of live biotherapeutic product therapy preferred rectally administered treatment while patients who had not received live biotherapeutic product therapy would be willing to consider it.
Paul Feuerstadt Centers For Disease Us Centers For Disease Yale School Of Medicine Yale School Of Medicine Paul Feuerstadt Yale School
Source: hcplive.com